Repeated immuno-embolisation of inoperable hepatic metastases from renal cell carcinoma;Repetitive Immunembolisation inoperabler Lebermetastasen beim Nierenzellkarzinom

Urologe - Ausgabe A

Volumn 35, Issue 4, 1996, Pages 310-314

  Pomer, S ^a,b   Brado, M ^b   Roeren, Th ^b   Brkovic, D ^a   Wiesel, M ^a   Staehler, G ^a   Keilholz, U ^b  

^a Abteilung für Urologie Bundeswehrkrankenhaus Hamburg   (Germany)

^b UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

immuno embolisation; interleukin 2; liver metastases; renal cancer

Indexed keywords

INTERLEUKIN 2;

ADULT; AGED; ARTICLE; ARTIFICIAL EMBOLISM; CLINICAL ARTICLE; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; FEVER; HUMAN; KIDNEY CARCINOMA; LIVER METASTASIS; MALE; TREATMENT OUTCOME;

ADULT; AGED; CARCINOMA, RENAL CELL; CHEMOEMBOLIZATION, THERAPEUTIC; FEMALE; HUMANS; INTERLEUKIN-2; IODIZED OIL; KIDNEY NEOPLASMS; LIVER NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; RECOMBINANT PROTEINS; TREATMENT OUTCOME;

EID: 0030036980     PISSN: 03402592     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Aebersold P, Hyatt C, Johnson S et al (1991) Lysis of autologous melanoma cells by tumor-infiltrating lymphocytes; association with clinical response. J Natl Cancer Inst 83: 932
2. Claussen CD (1994) Interventionell-radiologische Therapie bei malignen Lebertumoren. Fortschr Röntgenstr 160: 395-396
3. Elson PJ (1988) Prognostic factors for survival in patients with recurrent or metastatic renal cell carcinoma. Cancer Res 48: 7310-7313
4. Huppert PE, Geißler F, Duda SH, Lauchart W, Dette S, Dietz K, Brambs HJ, Claussen CD (1994) Chemoembolisation des hepatozellulären Karzinoms: Compatertomograpaische Befunde und klinische Resultate bei prospektiv repetitiver Therapie. Fortschr Röntgenstr 160: 425-432
5. Keilholz U, Scheibenbogen C, Brade M et al (1994) Regional adoptive immunotherapy with interleukin-2 and lymphokine-activated killer cells for liver metastasis. Eur J Cancer 30: A103
6. Kim B, Louie A (1992) Surgical resection following interleukin 2 therapy for metastatic renal cell carcinoma prolongs remission. Arch Surg 127: 1343-1349
7. Maldazys JD, de Kernion JB (1986) Prognostic factors in metastatic renal carcinoma. J Urol 136: 376-379
8. Palmer PA, Vinke J, Philip T, Negrier S, Atzpodien J, Kirchner H, Oskam R, Franks CR (1992) Prognostic factors for survival in patients with advanced renal cell carcinoma treated with recombinant interleukin-2. Ann Oncol 3: 475-480
9. Pomer S, Schirrmacher V, Thiele R, Löhrke H, Brkovic D, Staehler G (1995) Tumor response and 4 year survival data of patients with advanced renal cell carcinoma treated with autologous tumor vaccine and subcutaneous r-IL-2 and IFN-alpha 2b. Int J Oncol 6: 947-954
10. Thrasher JB, Paulson DF (1993) Prognostic factors in renal cancer. Urol Clin North Am 20: 247-262
11. Yagoda A, Abi-Rached B, Petrylak D (1995) Chemotherapy for advanced renal-cell carcinoma: 1983-1993. Semin Oncol 22: 42-60
12. Yamamoto M, Iizuka H, Fujii H, Matsuda M, Miura K (1993) Hepatic arterial infusion of interleukin-2 in advanced hepatocellular carcinoma. Acta Oncol 32: 43-51